Hematopoietic stem-cell transplantation (hsct) is a medical procedure that consists of
infusing stem cells after a short course of chemotherapy or radiotherapy, or both. It can be …

Hematopoietic cell transplantation is a curative treatment for a variety of hematologic
diseases. Advances in transplantation technology have reduced early transplant-related …

Background: Childhood cancer survivors are at higher risk of morbidity and mortality from
cardiovascular disease compared with the general population. Methods: Eight thousand five …

The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an
important connection between cancer treatment and its common late effect of cardiovascular …

Hematopoietic cell transplantation (HCT) recipients may be at an increased risk of
developing hypertension, diabetes, and dyslipidemia (referred to as cardiovascular risk …

Background: Hematopoietic stem cell transplantation (HSCT) is increasingly used to treat
multiple malignant and nonmalignant conditions. The risk for cardiovascular disease after …

Endocrine complications, including diabetes and metabolic syndrome, are highly prevalent
in childhood cancer survivors. These metabolic derangements may contribute to survivors' …

Advances in transplantation techniques and supportive care strategies have resulted in a
significant improvement in survival of those who have undergone treatment. However …

This review highlights long-term and late consequences of hematopoietic cell
transplantation (HCT) as well as strategies to manage or prevent complications that are …

Allogeneic hematopoietic stem cell transplantation (HSCT) has become an established
treatment modality for various hematological diseases. However, in allogeneic HSCT …